文献速递胃肠外科围术期管理与 ERAS

远端胃切除术后胃瘫综合征预测列线图及生存结局分析

Predictive nomogram for postsurgical gastroparesis syndrome and survival outcomes following distal gastrectomy: an in-depth analysis.
PubMed 文献 · Surg Endosc · 2026-02-26

该回顾性研究纳入2012至2023年山东大学齐鲁医院2490例根治性远端胃切除术患者,构建并验证术后胃瘫综合征(PGS)预测列线图,并分析PGS与长期生存的关联。列线图区分度良好(训练队列AUC 0.81,内部验证0.81,时间验证0.82),PGS患者生存结局显著更差,重叠加权分析显示PGS与较差生存独立相关(HR 1.41,95%CI 1.12-1.79,p=0.004)。

要点

  • 列线图可预测远端胃切除术后胃瘫综合征发生风险,AUC达0.81-0.82。
  • PGS与较差长期生存独立相关(HR 1.41,95%CI 1.12-1.79,p=0.004)。
  • 腹腔镜手术为保护因素(OR=0.47),Roux-en-Y吻合风险最高(OR=6.29)。

核心结论

  • 基于PGS危险因素构建的列线图预测模型对PGS发生具有潜在预测价值。
  • PGS与远端胃癌根治术后患者预后显著相关。

研究设计与样本

  • 回顾性分析2012年1月至2023年12月山东大学齐鲁医院行根治性远端胃切除术的患者。
  • 共纳入2490例患者,训练队列1934例(77.7%),验证队列556例(22.3%)。
  • 采用逻辑回归识别独立危险因素并构建PGS预测列线图,应用倾向性评分重叠加权(PSOW)减少混杂,采用加权Kaplan-Meier分析、log-rank检验和Cox回归评估PGS的预后影响。

主要发现

  • 238例发生PGS(训练队列187例)。
  • 独立危险因素包括手术时间延长(OR=1.01)、脑力劳动(OR=2.02)、糖尿病控制良好(OR=3.10)、糖尿病控制不佳(OR=4.95)、便秘史(OR=2.46)、术前幽门梗阻(OR=3.77)、围术期精神症状(OR=4.60)、Billroth II式吻合(OR=3.07)和Roux-en-Y吻合(OR=6.29)。
  • 保护因素为较高的术前血浆白蛋白(OR=0.96)和腹腔镜手术(OR=0.47)(均p<0.05)。
  • 列线图区分度和校准度良好,训练队列AUC为0.81,内部验证AUC为0.81,时间验证AUC为0.82。
  • PGS患者生存结局显著更差,重叠加权分析中PGS与较差生存独立相关(HR 1.41,95%CI 1.12-1.79,p=0.004)。

关键数值与推荐

  • 列线图AUC:训练队列0.81,内部验证0.81,时间验证0.82。
  • PGS与生存关联的HR为1.41(95%CI 1.12-1.79,p=0.004)。

临床怎么用

  • 可依据列线图危险因素(如手术时间、糖尿病控制状态、吻合方式、术前幽门梗阻、精神症状等)识别PGS高危患者。
  • 对高危患者可考虑优化围术期管理,如优先选择腹腔镜手术、改善术前白蛋白水平、关注精神症状及糖尿病控制。
  • PGS发生后应重视其与长期生存不良的关联,加强术后随访。

局限性

  • 单中心回顾性研究。
  • PGS与生存关联为观察性分析,虽采用PSOW减少混杂,仍不能排除残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postsurgical gastroparesis syndrome (PGS) is a common complication after distal gastrectomy that impairs quality of life and increases healthcare costs, yet its risk factors and long-term prognostic impact remain unclear. OBJECTIVE: To identify PGS risk factors after radical distal gastrectomy, develop and validate a model, and assess its association with long-term survival. METHODS: We retrospectively analyzed patients undergoing radical distal gastrectomy at Qilu Hospital of Shandong University between January 2012 and December 2023. Patients were assigned to training and validation cohorts by surgery date. Logistic regression was used to identify independent risk factors and develop a PGS prediction nomogram. Propensity score overlap weighting (PSOW) was applied to reduce confounding, and the prognostic impact of PGS was assessed using weighted Kaplan-Meier analysis, log-rank tests, and Cox regression. RESULTS: A total of 2490 patients were included (training cohort: 1934 [77.7%]; validation cohort: 556 [22.3%]), among whom 238 developed PGS (training cohort: 187). Independent risk factors included prolonged operative time (OR = 1.01), intellectual work (OR = 2.02), well-controlled diabetes (OR = 3.10), poorly controlled diabetes (OR = 4.95), history of constipation (OR = 2.46), preoperative pyloric obstruction (OR = 3.77), perioperative psychiatric symptoms (OR = 4.60), and Billroth II (OR = 3.07) or Roux-en-Y anastomosis (OR = 6.29). Protective factors were higher preoperative plasma albumin (OR = 0.96) and laparoscopic surgery (OR = 0.47) (all p < 0.05). The nomogram showed good discrimination and calibration, with AUCs of 0.81 for the training cohort, 0.81 for internal validation, and 0.82 for temporal validation. Patients with PGS exhibited significantly worse survival outcomes, and PGS was independently associated with poorer survival in the overlap-weighted analysis (HR 1.41, 95% CI 1.12-1.79, p = 0.004). CONCLUSIONS: The nomogram prediction model based on the risk factors for PGS occurrence has potential value in predicting the onset of PGS. PGS is significantly associated with the prognosis of patients after radical surgery for distal gastric cancer. CLINICAL TRIAL REGISTRATION: This study was registered at the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300069234).

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chen C, Guo J, Wei M, et al. Predictive nomogram for postsurgical gastroparesis syndrome and survival outcomes following distal gastrectomy: an in-depth analysis. Surg Endosc. 2026. PMID: 41748954. doi:10.1007/s00464-026-12673-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。